Search research articles
Contact Us
Filters
Showing results (21-30 of 56) with videos related to
Page
of 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
June 27, 2006
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference
Mack Roach, Gerald Hanks, Howard Thames, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 6, 2007
A new code for contrast in the primate visual pathway
Chris Tailby, Samuel G Solomon, Neel T Dhruv, et al.
American Journal of Surgery
|
August 5, 2015
Intraoperative radiotherapy for early breast cancer and age: clinical characteristics and outcomes
Andrea M Abbott, Lesly A Dossett, Loretta Loftus, et al.
BMC Microbiology
|
June 11, 2009
The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age
D Mariat, O Firmesse, F Levenez, et al.
Journal of Crohn'S & Colitis
|
December 31, 2014
Benefit of infliximab reintroduction after successive failure of infliximab and adalimumab in Crohn's disease
C Gagniere, L Beaugerie, B Pariente, et al.
Alimentary Pharmacology & Therapeutics
|
September 12, 2006
Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease
P Seksik, H Sokol, P Lepage, et al.
Gut
|
July 24, 2009
Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease
H Sokol, V Polin, A Lavergne-Slove, et al.
Revue Neurologique
|
December 1, 2009
Unilateral carotid granulomatous arteritis and Crohn's disease
C Gobron, R Kaci, H Sokol, et al.
La Revue De Medecine Interne
|
October 2, 2013
[Causes and differential diagnosis of flush]
E Lafont, H Sokol, M-E Sarre-Annweiler, et al.
Alimentary Pharmacology & Therapeutics
|
September 27, 2016
Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease
J Cosnes, H Sokol, A Bourrier, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 56) with videos related to
Sort By:
Page
of 6
International Journal of Radiation Oncology, Biology, Physics
|
June 27, 2006
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference
Mack Roach, Gerald Hanks, Howard Thames, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 6, 2007
A new code for contrast in the primate visual pathway
Chris Tailby, Samuel G Solomon, Neel T Dhruv, et al.
American Journal of Surgery
|
August 5, 2015
Intraoperative radiotherapy for early breast cancer and age: clinical characteristics and outcomes
Andrea M Abbott, Lesly A Dossett, Loretta Loftus, et al.
BMC Microbiology
|
June 11, 2009
The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age
D Mariat, O Firmesse, F Levenez, et al.
Journal of Crohn'S & Colitis
|
December 31, 2014
Benefit of infliximab reintroduction after successive failure of infliximab and adalimumab in Crohn's disease
C Gagniere, L Beaugerie, B Pariente, et al.
Alimentary Pharmacology & Therapeutics
|
September 12, 2006
Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease
P Seksik, H Sokol, P Lepage, et al.
Gut
|
July 24, 2009
Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease
H Sokol, V Polin, A Lavergne-Slove, et al.
Revue Neurologique
|
December 1, 2009
Unilateral carotid granulomatous arteritis and Crohn's disease
C Gobron, R Kaci, H Sokol, et al.
La Revue De Medecine Interne
|
October 2, 2013
[Causes and differential diagnosis of flush]
E Lafont, H Sokol, M-E Sarre-Annweiler, et al.
Alimentary Pharmacology & Therapeutics
|
September 27, 2016
Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease
J Cosnes, H Sokol, A Bourrier, et al.
Page
of 6